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Abstract
Background: Myelolipoma is an uncommon tumor comprising adipose tissue and normal hematopoietic cells and
mainly occurs in the adrenal cortex. Mediastinal myelolipoma is very rare; we report a case of posterior mediastinal
myelolipoma that required surgical resection.
Case Presentation: A 56-year-old male was diagnosed with a posterior mediastinal tumor by computed tomography.
The tumor was originally noted in 2005, and during follow-up in March 2014, it was found to have increased in size.
During consultation at our hospital, on magnetic resonance imaging (MRI), we considered the possibility that the tumor
was malignant. Consequently, we resected the tumor by video-assisted thoracic surgery (VATS). The histopathological
findings revealed that the tumor had undergone intrathoracic extramedullary hematopoiesis. However, after considering
the patient’s background and histopathological findings, we diagnosed the tumor as a thoracic extra-adrenal
myelolipoma.
Conclusions: Pathological analysis was instrumental in clarifying the diagnosis. We recommend surgery as a treatment
option for posterior mediastinal tumors.
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Background
Primary mediastinal myelolipoma is an extremely rare
benign tumor and should be considered in the differen-
tial diagnosis of posterior mediastinal tumors. It is diffi-
cult to distinguish myelolipoma and extramedullary
hematopoiesis using only histopathological examination.
Therefore, it is important to diagnose tumors by histo-
pathological findings associated with clinical back-
ground. Here, we report a surgical case of mediastinal
myelolipoma.
Case Presentation
A 56-year-old male was referred to our hospital for surgi-
cal resection of a posterior mediastinal tumor in July
2014. A local doctor had originally diagnosed the tumor
in 2005, and it had gradually increased in size until March
2014. The patient did not have any health problems or
symptoms suggestive of a history of hematologic disorder
or chronic anemia. Laboratory tests for tumor detection,
including those implementing tumor markers, were within
normal limits. A chest roentgenogram and computed
tomography (CT) showed a tumor mass shadow in the
right lower posterior mediastinum. The tumor was 4.3 cm
in diameter and was evident on the side of the T9 thoracic
vertebrae (Fig. 1). Magnetic resonance imaging (MRI)
revealed that the signal intensity of the tumor was low in
the T1 weighted image and disproportionately high in the
T2 weighted image (Fig. 2).
Differential diagnoses included neurogenic tumor, malig-
nant lymphoma, pleural mesothelioma, lipoma, liposar-
coma, or an extra-adrenal myelolipoma. We performed
tumor resection by video-assisted thoracic surgery (VATS).
Surgery revealed that the tumor in the posterior mediasti-
num was a well-encapsulated, elastic, soft, and dark red
mass (Fig. 3).
Histopathological findings of the resected specimens
revealed a predominantly mature adipose tissue with
hematopoietic tissue comprised of erythroblasts, mega-
karyocytes, and granulocytes (Fig. 4).
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Although extramedullary hematopoiesis was considered
as a differential diagnosis, the final diagnosis was a medias-
tinal extra-adrenal myelolipoma. The patient was dis-
charged with no complications on the fifth postoperative
day, and he has been well for 12 months postoperatively.
Discussion
Gierke first described Myelolipoma in 1905, and the term
“myelolipoma” was also coined by Oberling in 1929 [1–3].
Myelolipoma is a benign, nonfunctional tumor comprising
extensive hematopoietic tissue and sparse fatty tissue. Most
cases are hormonally inactive and found incidentally. The
extra-adrenal location of myelolipoma is extremely unusual,
and these tumors have been reported in the retroperito-
neum, stomach, liver, mediastinum, bilateral paravertebral
sulci [4], lung [5], presacral and perirenal spaces, and
thoracic spine [6].
Chest CT and MRI are useful in clinical diagnosis.
CT shows the mass shadow with a smooth, clear
border and a localized low-density area. However,
MRI shows high-intensity regions on both T1 and
T2-weighted images. These findings are helpful to
reach a definitive diagnosis [3, 7].
Fig. 1 Chest CT at our hospital showed a tumor in the right
posterior mediastinum (arrow). It measured 4.3 cm in diameter and
was located beside the 9th thoracic vertebrae
Fig. 2 Chest MRI revealed that the signal intensity of the tumor was low in the muscles in the T1 weighted image (a) and disproportionately
high in the T2 weighted image (b). The tumor invaded neither the intervertebral foramen nor the vertebral body
Fig. 3 Operation findings identified a dark red, well-encapsulated,
and elastic soft mass in the posterior mediastinum
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Myelolipomas located in the mediastinum are usually
asymptomatic, and there have been no reports of myelo-
lipomas transforming into malignant tumors. The
decision-making process for surgical resection is based
on a number of factors, including increased tumor size
or local symptoms, such as chest pain, hemothorax, or
paralysis, caused by spinal cord compression [3, 8]. We
considered neurogenic tumor, malignant lymphoma,
liposarcoma, and pleural mesothelioma in the differen-
tial diagnosis but conclusive evidence for these diagnoses
was lacking. A CT-guided fine needle biopsy has been
reported useful to avoid surgery. However, the use of
needle biopsy can augment the risk of bleeding and
tumor rupture [9, 10]. The differential diagnosis of thor-
acic extra-adrenal myelolipoma and thoracic extrame-
dullary hematopoiesis cannot be confirmed purely on a
pathological basis as both these conditions feature
hematopoietic elements and adipose tissue [11]. Although
thoracic extramedullary hematopoiesis occurs at multiple
sites as lobulated tumors in the thoracic paravertebral
area, thoracic extra-adrenal myelolipoma predominantly
occurs at a single site as an encapsulated tumor [8].
Patients with extramedullary hematopoiesis usually
have hematological disorders, such as anemia, leukemia,
and myelodysplastic syndrome. However, extra-adrenal
myelolipomas are not typically associated with anemia
or other hematological disorders. From the histopatho-
logical findings and the clinical background of the pa-
tient, we diagnosed the tumor to be an extra-adrenal
myelolipoma. Histopathological findings are effective el-
ements in clarifying the diagnosis. There is no standard
treatment for primary mediastinal myelolipoma; how-
ever, if such tumors start to increase in size or cause
symptoms, they should be surgically resected. Due to
the progressive enlargement of the tumor and the
uncertain pre-operative diagnosis of this case, we re-
moved the tumor by VATS. No recurrence or malignant
transformation of primary mediastinal myelolipomas has
been reported, so the long-term prognosis is very good.
Conclusions
We experienced a case of myelolipoma in the mediasti-
num. Although primary mediastinal myelolipoma is very
rare, knowledge of this tumor is important for correct
differential diagnosis of the mediastinal tumor.
Consent
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Fig. 4 Microscopic examination showed adipocytes mixed with
hematopoietic elements, including megakaryocytes (arrow) and
regular granulopoietic and erythropoietin lineage cells
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